Literature DB >> 28225145

Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences.

Marcus Johansson1, Lena Manfredsson1, Annika Wistedt1, Lena Serrander2, Ivar Tjernberg3,4.   

Abstract

The purpose of this study was to assess the seroprevalence of C6 ELISA antibodies in healthy blood donors in Kalmar County, Sweden, in relation to age, sex and time of year (peak season vs off season). In addition, we wanted to assess serological status over time in a group of C6 ELISA seropositive blood donors. Sera were collected from 273 (131 women, 142 men) blood donors in autumn 2011 and 300 (144 women, 156 men) in winter 2014. All sera were analysed in the C6 ELISA and the results were interpreted according to the manufacturer's instructions. The seroprevalence was 22% (females 16%, males 28%) in 2011 and 24% (females 15%, males 33%) in 2014. The seroprevalence was significantly higher in males and increased with age. The highest seroprevalence was observed among elderly men, 60-70 years old (46% in 2011 and 52% in 2014). No significant difference was detected in seropositivity between the samples collected in winter and autumn. All (34/34) seropositive blood donors followed over time remained seropositive at follow-up after 22-29 months. C6 ELISA seroprevalence in healthy blood donors is high in Kalmar County, thereby reducing the specificity of a positive test result regarding the clinical diagnosis of Lyme borreliosis (LB). Although C6 seroprevalence appears not to be affected by seasonal sample time, it varies greatly with age and sex. A careful evaluation of pre-test probability is therefore of the utmost importance in the clinical diagnosis of LB, especially in elderly men. We suggest that colleagues in other endemic regions also consider initiating similar evaluations to optimize the laboratory and clinical diagnosis of LB in relation to age and sex.
© 2017 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C6 ELISA; Lyme borreliosis; blood donors; seroprevalence

Mesh:

Substances:

Year:  2017        PMID: 28225145     DOI: 10.1111/apm.12664

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study.

Authors:  B J A Hoeve-Bakker; Mark Jonker; Afke H Brandenburg; P Martijn den Reijer; Foekje F Stelma; Alje P van Dam; Tamara van Gorkom; Karen Kerkhof; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-03-17

2.  Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis.

Authors:  Yan Dong; Guozhong Zhou; Wenjing Cao; Xin Xu; Yu Zhang; Zhenhua Ji; Jiaru Yang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Jing Kong; Shiyuan Wen; Bingxue Li; Peng Yue; Aihua Liu; Fukai Bao
Journal:  BMJ Glob Health       Date:  2022-06

3.  IgE reactivity to α-Gal in relation to Lyme borreliosis.

Authors:  Ivar Tjernberg; Carl Hamsten; Danijela Apostolovic; Marianne van Hage
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 4.  When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children.

Authors:  Krzysztof Orczyk; Joanna Świdrowska-Jaros; Elżbieta Smolewska
Journal:  Pediatr Rheumatol Online J       Date:  2017-05-08       Impact factor: 3.054

5.  Clinical Course, Serologic Response, and Long-Term Outcome in Elderly Patients with Early Lyme Borreliosis.

Authors:  Katarina Boršič; Rok Blagus; Tjaša Cerar; Franc Strle; Daša Stupica
Journal:  J Clin Med       Date:  2018-12-02       Impact factor: 4.241

6.  Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.

Authors:  Malin Lager; Ram B Dessau; Peter Wilhelmsson; Dag Nyman; Guro F Jensen; Andreas Matussek; Per-Eric Lindgren; Anna J Henningsson; Haitham Baqir; Lena Serrander; Marcus Johansson; Ivar Tjernberg; Ingerid Skarstein; Elling Ulvestad; Nils Grude; Anne-Berit Pedersen; Anders Bredberg; Renate Veflingstad; Linda Wass; Josefin Aleke; Marika Nordberg; Clara Nyberg; Linda Perander; Christina Bojesson; Emma Sjöberg; Åslaug R Lorentzen; Randi Eikeland; Sølvi Noraas; Gunnel Al Henriksson; Gábor Petrányi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-09       Impact factor: 3.267

7.  Antibiotic Use and Long-Term Outcome in Patients with Tick-Borne Encephalitis and Co-Infection with Borrelia Burgdorferi Sensu Lato in Central Europe. A Retrospective Cohort Study.

Authors:  Maša Velušček; Rok Blagus; Tjaša Cerar Kišek; Eva Ružić-Sabljić; Tatjana Avšič-Županc; Fajko F Bajrović; Daša Stupica
Journal:  J Clin Med       Date:  2019-10-20       Impact factor: 4.241

8.  Complement activation in individuals with previous subclinical Lyme borreliosis and patients with previous Lyme neuroborreliosis.

Authors:  Hanna Carlsson; Kerstin Sandholm; Haben Woldu Haddish; Lars Brudin; Kristina Nilsson Ekdahl; Ivar Tjernberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-31       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.